Nuclera Announces Appointment of Colin Barnes and Kristine Friscino to its Executive Leadership Team

Nuclera, a biotechnology company accelerating protein expression workflows, has announced the appointment of two new members of their team: Colin Barnes, as VP of Intellectual Property and Kristine Friscino, as AVP of Marketing.  

 “We are so excited to have both Colin and Kristine on board. In this challenging labor market, we’ve been extremely fortunate to source top-tier, experienced industry professionals to build out our leadership team” said Dr. Michael Chen, CEO and cofounder of Nuclera. “These hires fill the last two open positions on our executive leadership team and we’re excited to now fully focus on the commercial launch of our eProtein desktop bioprinter in 2023.”

Read More